Specialty diagnostics Company Precipio Inc (NASDAQ: PRPO), has announced that as part of management’s appraisal of its present funding provisions, it has ended the equity line financing arrangement it had in place with Lincoln Park Capital. As a result, the company shares fell -5.5140% to end trading Tuesday at $3.77 per share – […]